Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults Journal Article


Authors: Litzow, M. R.; Sun, Z.; Mattison, R. J.; Paietta, E. M.; Roberts, K. G.; Zhang, Y.; Racevskis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; Wieduwilt, M. J.; Liedtke, M.; Bergeron, J.; Wood, B. L.; Zhao, Y.; Wu, G.; Chang, T. C.; Zhang, W.; Pratz, K. W.; Dinner, S. N.; Frey, N.; Gore, S. D.; Bhatnagar, B.; Atallah, E.L.; Uy, G. L.; Jeyakumar, D.; Lin, T. L.; Willman, C. L.; DeAngelo, D. J.; Patel, S. B.; Elliott, M. A.; Advani, A. S.; Tzachanis, D.; Vachhani, P.; Bhave, R. R.; Sharon, E.; Little, R. F.; Erba. H. P.; Stone, R. M.; Luger, S. M.; Mullighan, C. G.; Tallman, M. S.
Article Title: Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults
Journal Title: New England Journal of Medicine
Volume: 391
Issue: 4
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2024-07-25
Start Page: 320
End Page: 333
Language: English
DOI: 10.1056/NEJMoa2312948
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
PUBMED: 39047240
PMCID: PMC11334054
DOI/URL:
Notes: Accession Number: 178710663 -- Entry Date: In Process -- Revision Date: 20240731 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 0255562. -- Source: CINAHL Plus with Full Text
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
  2. Yanming Zhang
    199 Zhang